Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s12891-017-1713-z
Published Online: 2017-08-30
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Costas, Bronier
Coleman, Stephen
Kaufman, Greg
James, Robert
Cohen, Brian
Gaston, R. Glenn
Funding for this research was provided by:
Auxilium Pharmaceuticals, Inc (Study funding)
Endo Pharmaceuticals Inc (Writing and editorial support)
